Literature DB >> 7764377

Anti-complementary neutral polysaccharides from leaves of Artemisia princeps.

Q C Zhao1, H Kiyohara, H Yamada.   

Abstract

The three anti-complementary neutral polysaccharides, IA-1, IB-1 and IC-1, were purified from the leaves of Artemisia princeps by anion-exchange chromatography, gel filtration and affinity chromatography. The order of the anti-complementary activity was IA-1 > IB-1 > IC-1. The polysaccharides appeared to be homogeneous from the results of gel filtration, HPLC and electrophoresis. The M(r)s of IA-1 IB-1 and IC-1 were estimated to be 56,000, 16,000, and 7000, respectively, by HPLC. IA-1 consisted mainly of arabinose (Ara), galactose (Gal) and glucose (Glc) in molar ratios of 1.8:1.0:0.9, whereas IB-1 and IC-1 were composed mainly of Ara, mannose (Man), Gal and Glc in molar ratios of 3.5:0.8:1.0:0.8 and 2.3:3.5:1.0:3.2, respectively. Methylation analysis, 13C NMR and enzymic digestion suggested that IA-1 mainly contained alpha-L-(1-->3,5)-arabinan, beta-D-(1-->6)-linked Gal and beta-D-(1-->3)-linked Glc. IB-1 also consisted mainly of alpha-L-(1-->3,5)-arabinan and beta-D-(1-->6)-linked Gal, whereas IC-1 was composed mainly of beta-D-(1-->4)- linked Glc and alpha- or beta-D-(1-->4)-linked Man.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7764377     DOI: 10.1016/s0031-9422(00)90512-0

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  2 in total

1.  Anticoagulant and Antiplatelet Activities of Artemisia princeps Pampanini and Its Bioactive Components.

Authors:  Ri Ryu; Un Ju Jung; Hye-Jin Kim; Wonhwa Lee; Jong-Sup Bae; Yong Bok Park; Myung-Sook Choi
Journal:  Prev Nutr Food Sci       Date:  2013-09

2.  Application of Partial Internal Transcribed Spacer Sequences for the Discrimination of Artemisia capillaris from Other Artemisia Species.

Authors:  Eui Jeong Doh; Seung-Ho Paek; Guemsan Lee; Mi-Young Lee; Seung-Eun Oh
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-30       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.